Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Karyopharm Therapeutics Inc (KPTI)

83 + Investors. Track Smart Money conviction in KPTI. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
4Q ▲
Buyers last Q
71%

Smart Money Signals — KPTI

Based on 83 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added KPTI than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 65% of 3.0Y high

65% of all-time peak
Only 83 funds hold KPTI today versus a peak of 128 funds at 2023 Q2 — just 65% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
🚀

Fast accumulation — +66% more funds vs a year ago

fund count last 6Q
+33 new funds entered over the past year (+66% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 71% buying

63 buying26 selling
Last quarter: 63 funds were net buyers (29 opened a brand new position + 34 added to an existing one). Only 26 were sellers (10 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~29 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 11 → 8 → 24 → 29. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

59% of holders stayed for 2+ years

■ 59% conviction (2yr+) ■ 19% medium ■ 22% new
49 out of 83 hedge funds have held KPTI for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +170%, value -64%

Value
-63%
Shares
+170%
Last quarter: funds added +170% more shares while total portfolio value only changed -64%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

5 → 11 → 8 → 24 → 29 new funds/Q
New funds entering each quarter: 11 → 8 → 24 → 29. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 71% veterans vs 20% newcomers

■ 71% veterans ■ 9% 1-2yr ■ 20% new
Entry-cohort mix of 100 holders: 71 (71%) are 2+ year veterans, 9 entered 1–2 years ago, and 20 (20%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
📋

Smaller funds dominant — 13% AUM from top-100

13% from top-100 AUM funds
19 of 77 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
2.6
out of 10
Low Exit Risk
Exit risk score 2.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — KPTI

In 2026 Q1, 63 hedge funds were net buyers of KPTI (29 opened a new position, 34 added to an existing one), while 26 reduced or exited (10 trimmed, 16 sold completely) — a 71% buyer ratio, indicating clear institutional accumulation. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 83.

Hedge Fund Ownership: KPTI

How many hedge funds hold KPTI — quarterly history vs. share price
Quarterly hedge fund ownership of KPTI vs. share price

Market Analysis: KPTI

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: KPTI

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Karyopharm Therapeutics Inc (KPTI) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much KPTI has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
KPTI
nan%
XLV
+2.1%

KPTI outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
KPTI
nan%
XLV
+3.2%

Since the filing became public, KPTI outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

7 top-rated funds 0 high-conviction
Consensus
3.9
/ 10
breadth
×
Elite
1.1
/ 10
conviction
Hedge Fund Positioning: KPTI
83 + Investors

Track Smart Money conviction in KPTI. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 83 70 18.57%
13F Shares 25M 9M 170.04%
Total Value $133M $363M -63.52%
New Positions 29 24 +5
Increased Positions 34 21 +13
Closed Positions 16 11 +5
Reduced Positions 8 7 +1
Total Calls 16 4 300.0%
Total Puts 7 3 133.33%
PUT/CALL Ratio 0.44 0.75 Bullish

Statistics: KPTI

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

83 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in KPTI. Verified SEC 13F-HR filings.

QUARTER:
Top 25 KPTI holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Squadron Capital Management LLC 1.53% 750,000 $4.2M
2 Ally Bridge Group (NY) LLC 1.12% 250,000 $1.4M
3 Catalio Capital Management, LP 1.04% 897,709 $5.0M
4 Avidity Partners Management LP 0.87% 463,741 $3.9M
5 Commodore Capital LP 0.63% 1,950,000 $10.9M
6 Acorn Capital Advisors, LLC 0.46% 287,826 $1.6M
7 Ikarian Capital, LLC 0.42% 920,000 $5.1M
8 Ikarian Capital, LLC 0.42% 920,000 $5.1M
9 Ikarian Capital, LLC 0.33% 733,435 $4.1M
10 Birchview Capital, LP 0.27% 83,952 $468K
11 Diadema Partners LP 0.23% 241,300 $1.3M
12 Boxer Capital Management, LLC 0.22% 302,536 $1.7M
13 Affinity Asset Advisors, LLC 0.14% 500,000 $2.8M
14 Ra Capital Management, L.P. 0.11% 1,917,354 $10.7M
15 Soleus Capital Management, L.P. 0.10% 440,000 $2.5M
16 Silverback Asset Management LLC 0.08% 100,000 $557K
17 Eversept Partners, LP 0.08% 276,174 $1.5M
18 ADAR1 Capital Management, LLC 0.07% 205,200 $1.1M
19 DAFNA Capital Management LLC 0.06% 45,800 $255K
20 Tetragon Partners GP Ltd 0.06% 52,984 $295K
21 Tetragon Partners GP Ltd 0.05% 50,000 $278K
22 Silverback Asset Management LLC 0.05% 65,000 $362K
23 Velan Capital Investment Management LP 0.05% 15,000 $84K
24 ADAR1 Capital Management, LLC 0.04% 136,736 $762K
25 Caption Management, LLC 0.04% 1,086,900 $6.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Karyopharm Therapeutics Inc (KPTI)

What does the Smart Money Trend signal show for KPTI?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added KPTI than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for KPTI?

More buyers than sellers — 71% buying: Last quarter: 63 funds were net buyers (29 opened a brand new position + 34 added to an existing one). Only 26 were sellers (10 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for KPTI holders?

Smaller funds dominant — 13% AUM from top-100: 19 of 77 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held KPTI?

59% of holders stayed for 2+ years: 49 out of 83 hedge funds have held KPTI for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Karyopharm Therapeutics Inc (KPTI) following the 2026 Q1 hedge fund 13F filings?

As of today, KPTI has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), KPTI has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →